Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2014, Article ID 819034, 7 pages
http://dx.doi.org/10.1155/2014/819034
Clinical Study

Procalcitonin Clearance for Early Prediction of Survival in Critically Ill Patients with Severe Sepsis

Department of Anaesthesiology and Intensive Care, Kulliyyah of Medicine, International Islamic University Malaysia, Jalan Hospital Campus, 25000 Kuantan, Pahang, Malaysia

Received 7 November 2013; Revised 13 January 2014; Accepted 13 January 2014; Published 24 February 2014

Academic Editor: Timothy E. Albertson

Copyright © 2014 Mohd Basri Mat Nor and Azrina Md Ralib. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Wolff and L. Bouadma, “What procalcitonin brings to management of sepsis in the ICU,” Critical Care, vol. 14, no. 6, article 1007, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Bouadma, C.-E. Luyt, F. Tubach et al., “Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial,” The Lancet, vol. 375, no. 9713, pp. 463–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. K. Matthaiou, G. Ntani, M. Kontogiorgi, G. Poulakou, A. Armaganidis, and G. Dimopoulos, “An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients,” Intensive Care Medicine, vol. 38, pp. 940–949, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. N. J. Soni, D. J. Samson, J. L. Galaydick et al., “Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis,” Journal of Hospital Medicine, vol. 8, no. 9, pp. 530–540, 2013. View at Google Scholar
  5. A. Hohn, S. Schroeder, A. Gehrt et al., “Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock,” BMC Infectious Diseases, vol. 13, p. 158, 2013. View at Publisher · View at Google Scholar
  6. G. P. Castelli, C. Pognani, M. Meisner, A. Stuani, D. Bellomi, and L. Sgarbi, “Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction,” Critical Care, vol. 8, no. 4, pp. R234–R242, 2004. View at Google Scholar · View at Scopus
  7. K. Reinhart and M. Meisner, “Biomarkers in the critically Ill patient: procalcitonin,” Critical Care Clinics, vol. 27, no. 2, pp. 253–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Meisner, K. Tschaikowsky, T. Palmaers, and J. Schmidt, “Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS,” Critical Care, vol. 3, no. 1, pp. 45–50, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-L. Vincent, Y. Sakr, C. L. Sprung et al., “Sepsis in European intensive care units: results of the SOAP study,” Critical Care Medicine, vol. 34, no. 2, pp. 344–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Viallon, S. Guyomarc'h, O. Marjollet et al., “Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin,” European Journal of Emergency Medicine, vol. 15, no. 1, pp. 26–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. M. Tang, G. D. Eslick, J. C. Craig, and A. S. McLean, “Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis,” Lancet Infectious Diseases, vol. 7, no. 3, pp. 210–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Karlsson, M. Heikkinen, V. Pettilä et al., “Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study,” Critical Care, vol. 14, no. 6, article R205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. F.-S. Meng, L. Su, Y.-Q. Tang, Q. Wen, Y.-S. Liu, and Z.-F. Liu, “Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality,” Clinical Biochemistry, vol. 42, no. 10-11, pp. 1025–1031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Tschaikowsky, M. Hedwig-Geissing, G. G. Braun, and M. Radespiel-Troeger, “Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis,” Journal of Critical Care, vol. 26, no. 1, pp. 54–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Seligman, M. Meisner, T. C. Lisboa et al., “Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia,” Critical Care, vol. 10, no. 5, article R125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-E. Luyt, V. Guérin, A. Combes et al., “Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 1, pp. 48–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. U. Jensen, L. Heslet, T. H. Jensen, K. Espersen, P. Steffensen, and M. Tvede, “Procalcitonin increase in early identification of critically ill patients at high risk of mortality,” Critical Care Medicine, vol. 34, no. 10, pp. 2596–2602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. C. Ruiz-Rodríguez, J. Caballero, A. Ruiz-Sanmartin et al., “Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study,” Medicina Intensiva, vol. 36, pp. 475–480, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Suberviola, A. Castellanos-Ortega, A. González-Castro, L. A. García-Astudillo, and B. Fernández-Miret, “Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock,” Medicina Intensiva, vol. 36, no. 3, pp. 177–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. C. Bone, R. A. Balk, F. B. Cerra et al., “American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, pp. 864–874, 1992. View at Publisher · View at Google Scholar
  21. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference,” Critical Care Medicine, vol. 31, no. 4, pp. 1250–1256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Kumar and A. Indrayan, “Receiver operating characteristic (ROC) curve for medical researchers,” Indian Pediatrics, vol. 48, no. 4, pp. 277–287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008,” in Critical Care Medicine, P. Hora, Ed., pp. 296–327, Springer, 2008. View at Google Scholar
  24. J. Guan, Z. Lin, and H. Lue, “Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10 ng/mL,” Shock, vol. 36, no. 6, pp. 570–574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Claeys, S. Vinken, H. Spapen et al., “Plasma procalcitonin and c-reactive protein in acute septic shock: clinical and biological correlates,” Critical Care Medicine, vol. 30, no. 4, pp. 757–762, 2002. View at Google Scholar · View at Scopus
  26. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Google Scholar · View at Scopus
  27. R. P. Dellinger, M. M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012,” Critical Care Medicine, vol. 41, pp. 580–637, 2013. View at Publisher · View at Google Scholar
  28. J. T. M. Geok, T. L. Ling, T. C. Cheng et al., Malaysian Registry of Intensive Care Report, 2012, www.mric.org.my.
  29. A. Kumar, D. Roberts, K. E. Wood et al., “Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock,” Critical Care Medicine, vol. 34, no. 6, pp. 1589–1596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. P. E. Charles, C. Tinel, S. Barbar et al., “Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome,” Critical Care, vol. 13, no. 2, article R38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Schuetz, P. Maurer, V. Punjabi et al., “Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients,” Critical Care, vol. 17, no. 3, p. R115, 2013. View at Google Scholar
  32. A.-P. Georgopoulou, A. Savva, E. J. Giamarellos-Bourboulis et al., “Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis,” Journal of Critical Care, vol. 26, no. 3, pp. 331–e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. E. Jones, S. Trzeciak, and J. A. Kline, “The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation,” Critical Care Medicine, vol. 37, no. 5, pp. 1649–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus